Kostev K - Search Results

1

The impact of treatment compliance on fracture risk in women with breast cancer treated with aromatase inhibitors in the United Kingdom.

Schmidt N, Jacob L, Coleman R, Kostev K, Hadji P. Schmidt N, et al. Among authors: kostev k. Breast Cancer Res Treat. 2016 Jan;155(1):151-7. doi: 10.1007/s10549-015-3661-3. Epub 2015 Dec 19. Breast Cancer Res Treat. 2016. PMID: 26687384

2

Relation of the first hypertension-associated event with medication, compliance and persistence in naïve hypertensive patients after initiating monotherapy.

Mathes J, Kostev K, Gabriel A, Pirk O, Schmieder RE. Mathes J, et al. Among authors: kostev k. Int J Clin Pharmacol Ther. 2010 Mar;48(3):173-83. doi: 10.5414/cpp48173. Int J Clin Pharmacol Ther. 2010. PMID: 20197011

3

GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates.

Hadji P, Claus V, Ziller V, Intorcia M, Kostev K, Steinle T. Hadji P, et al. Among authors: kostev k. Osteoporos Int. 2012 Jan;23(1):223-31. doi: 10.1007/s00198-011-1535-z. Epub 2011 Feb 10. Osteoporos Int. 2012. PMID: 21308365

4

Cost comparison of outpatient treatment with granulocyte colony-stimulating factors (G-CSF) in Germany.

Hadji P, Kostev K, Schröder-Bernhardi D, Ziller V. Hadji P, et al. Among authors: kostev k. Int J Clin Pharmacol Ther. 2012 Apr;50(4):281-9. doi: 10.5414/cp201633. Int J Clin Pharmacol Ther. 2012. PMID: 22456299

5

Persistence and compliance of medications used in the treatment of osteoporosis--analysis using a large scale, representative, longitudinal German database.

Ziller V, Kostev K, Kyvernitakis I, Boeckhoff J, Hadji P. Ziller V, et al. Among authors: kostev k. Int J Clin Pharmacol Ther. 2012 May;50(5):315-22. doi: 10.5414/cp201632. Int J Clin Pharmacol Ther. 2012. PMID: 22541835

6

Effects of a low-dose oral estrogen only treatment on bone mineral density and quantitative ultrasonometry in postmenopausal women.

Ziller M, Herwig J, Ziller V, Kauka A, Kostev K, Hadji P. Ziller M, et al. Among authors: kostev k. Gynecol Endocrinol. 2012 Dec;28(12):1002-5. doi: 10.3109/09513590.2012.705369. Epub 2012 Jul 26. Gynecol Endocrinol. 2012. PMID: 22835159 Free article.

7

Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis.

Hadji P, Ziller V, Kyvernitakis J, Bauer M, Haas G, Schmidt N, Kostev K. Hadji P, et al. Among authors: kostev k. Breast Cancer Res Treat. 2013 Feb;138(1):185-91. doi: 10.1007/s10549-013-2417-1. Epub 2013 Jan 20. Breast Cancer Res Treat. 2013. PMID: 23334803

8

Persistence with bisphosphonates in patients with metastatic breast cancer: a retrospective database analysis.

Hadji P, Ziller V, Kyvernitakis J, Schmidt N, Kostev K. Hadji P, et al. Among authors: kostev k. J Cancer Res Clin Oncol. 2013 Jul;139(7):1149-55. doi: 10.1007/s00432-013-1427-z. Epub 2013 Apr 4. J Cancer Res Clin Oncol. 2013. PMID: 23552873

9

Prevalence of female subfertility in German gynecological practices.

Ziller V, Hadji P, Thielscher C, Ziller M, Kostev K. Ziller V, et al. Among authors: kostev k. Gynecol Endocrinol. 2013 Aug;29(8):767-70. doi: 10.3109/09513590.2013.798274. Epub 2013 Jun 5. Gynecol Endocrinol. 2013. PMID: 23738676 Free article.

10

Adherence in tamoxifen therapy after conversion to a rebate pharmaceutical in breast cancer patients in Germany.

Kostev K, May U, Hog D, Eisel J, Kremmers T, Kosteic M, Waehlert L, Hadji P. Kostev K, et al. Int J Clin Pharmacol Ther. 2013 Dec;51(12):969-75. doi: 10.5414/CP201969. Int J Clin Pharmacol Ther. 2013. PMID: 24120719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

668 results

Search Page

Filters